Taken together, these data demonstrate that Orientin, which alleviates HAEC inflammation and pyroptosis through regulating the MARCH8/NLRP3 axis, might be a potential candidate for treating diabetes-accelerated atherosclerosis. This evidence concerns the gene NLRP3 and atherosclerosis.